Invesco QQQ TrustQQQ

On 24 July 2026, the Invesco QQQ Trust (QQQ) is trading as the poster child for the Nasdaq-100, a 1999-vintage ETF that has managed the neat trick of turning the dot-com bust, the 2008 crisis, and the 2020 pandemic into a 27-year winning streak against the S&P 500. The fund’s marketing arm calls this “relative strength,” but the boring truth is that 84% of its weight sits in 64 companies that collectively own the patents and pipelines of 35 “disruptive technology” buckets from AI to energy transition. Put another way, QQQ is a concentrated bet on the companies that file the patents, not the scientists who write them. (source: Invesco QQQ ETF Performance, https://www.invesco.com/qqq-etf/en/innovation-performance.html)

What QQQ actually owns is a concentrated slice of seven megacap tech titans-Meta, Apple, Microsoft, Amazon, Nvidia, Tesla, and Alphabet-whose combined weight is drifting toward 50%. If those seven sneeze, the whole fund catches pneumonia, and the issuer knows it: its official innovation pitch features a glossy card titled “Class C 4.13%,” a polite reminder that the closer you get to the AI ecosystem, the more the distribution desk gets paid to let you in. The fund’s total expense ratio sits at 0.18%, which sounds modest until you do the compounding math over a decade. (source: Innovation in action - Invesco QQQ, https://www.invesco.com/qqq-etf/en/innovation.html)

The Invesco QQQ Equal Weight ETF tries to market itself as the antidote to concentration risk, giving each of the 100 Nasdaq-100 constituents an equal vote. Yet the fine print reveals the same issuer, the same trust structure, and the same fee pipeline. Rebalancing is handled by Invesco Contribution Manager, and shares are distributed by Invesco Distributors, Inc.-a neat circularity that ensures the wrapper’s economics remain inside the house regardless of the theme. The fund’s official page does not disclose how often it rebalances or what trading costs accrue, which is odd given that the issuer’s broader ETF lineup is marketed as “cost-effective, tax-efficient tools for maximizing your investments.” (source: Invesco QQQ Equal Weight ETF, https://www.invesco.com/us/en/financial-products/etfs/invesco-qqq-equal-weight-etf.html; Invesco ETFs, https://www.invesco.com/us/en/solutions/invesco-etfs.html)

Mechanically, QQQ is a unit investment trust that tracks the Nasdaq-100 Index via a full-replication strategy. Its prospectus, filed with the SEC, confirms the index’s 100-constituent limit and the fund’s mandate to hold each security in proportion to its index weight. The trust structure avoids the operational drag of sampling, but it also means the fund cannot lend securities or use derivatives to offset fee drag. Liquidity is ample: average daily volume across venues hovers above 30 million shares, and the bid-ask spread is routinely sub-2 basis points, a sign that the wrapper’s real job is to channel flows into the underlying basket without friction. (source: SEC EDGAR fund search for QQQ, https://www.sec.gov/edgar/search/#/q=QQQ; Nasdaq QQQ market activity, https://www.nasdaq.com/market-activity/etf/qqq)

What changed this week: nothing fundamental. The index reconstitution cycle hasn’t arrived, and the issuer’s innovation pages remain unchanged since the last update. The fund’s official performance page still claims a long-term record of beating the S&P 500, which is true if you ignore survivor bias and survivor fees. What remains unproven is whether the “full AI ecosystem” pitch justifies a 0.18% fee when the top seven holdings are the same companies that dominate the equal-weight version after fees. The chart route is available via Nasdaq, but the file carries no invented levels or commentary. (source: Invesco QQQ official fund home, https://www.invesco.com/qqq-etf/en/home.html; FINRA Fund Analyzer, https://tools.finra.org/fund_analyzer/)

Evidence gaps: the issuer does not disclose the fund’s annual turnover, trading costs, or the real-world tax drag of Class C shares. The equal-weight fund’s rebalancing cadence is also undisclosed, leaving investors to trust that the fee engine is running in their favour rather than the issuer’s. A deeper file would include the fund’s actual replication costs, the SEC’s recent comment-letter exchanges on the equal-weight methodology, and the issuer’s latest Form N-CEN filing, which is due in August. Until then, the wrapper’s innovation story remains a marketing asset-not a documented operational reality. (source: SEC EDGAR fund search for QQQ, https://www.sec.gov/edgar/search/#/q=QQQ)